Meningococcal Infections Completed Phase 3 Trials for Poliovirus type 2 antigen (formaldehyde inactivated) (DB10796)

Also known as: Infections, Meningococcal / Meningococcal Infection / Meningococcal disease / Unspecified meningococcal infection / Meningococcal infection, unspecified / Neisseria meningitidis infection NOS

IndicationStatusPhase
DBCOND0032814 (Meningococcal Infections)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00614614Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014Prevention
NCT00289783Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate VaccinePrevention